MCG Ambulatory Care: New Evidence for Gene Therapy (Beta Thalassemia)

MCG Ambulatory Care: New Evidence for Insulin PumpsПодробнее

MCG Ambulatory Care: New Evidence for Genetic TestingПодробнее

MCG & Genetic Medicine: Ambulatory CareПодробнее

MCG Ambulatory CareПодробнее

Beta Thalassemia and Sickle Cell Gene TherapyПодробнее

Gene Therapy Cure for Beta ThalassemiaПодробнее

MCG Ambulatory Care and Genetic TestingПодробнее

TCT highlights: long-term outcomes of beti-cel gene therapy for β-thalassemiaПодробнее

Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MDПодробнее

The Potential for Gene Therapy in Beta-ThalassemiaПодробнее

Beti-cel gene therapy for transfusion-dependent β-thalassemia: 7-year follow up dataПодробнее

Transforming Lives: Discover the New Breakthrough Cure for Beta ThalassemiaПодробнее

Overview: Novel Therapies in ThalassemiaПодробнее

Gene therapy for beta thalassemiaПодробнее

Preliminary Results from Gene Therapy in Patients with Beta ThalassemiaПодробнее

The Cost and Safety of Gene Therapy in Beta-ThalassemiaПодробнее

Gene Therapy Treatment for Thalassemia WebinarПодробнее

John Rasko, ASH 2019: Gene Therapy for Beta-HemoglobinopathiesПодробнее

$2.8M Gene Therapy Could Be A Game-Changer For Patients With Severe AnemiaПодробнее